PATENT CLAIM ANALYSIS

Application Number: 15916494
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "007600"]

Abstract:
The present invention relates to compositions and methods for the treatment of heart failure.

Claim (Index 6):
The composition of  claim 1 , wherein said \u03b2AR-blocker is at least one selected from the group consisting of Bisoprolol, Carvedilol, Carvedilol phosphate, Metoprolol Succinate, Nebivolol, a functional fragment of Bisoprolol, a functional fragment of Carvedilol, a functional fragment of Carvedilol phosphate, a functional fragment of Metoprolol Succinate, a functional fragment of Nebivolol, an analog of Bisoprolol, an analog of Carvedilol, an analog of Carvedilol phosphate, an analog of Metoprolol Succinate, an analog of Nebivolol, a derivative of Bisoprolol, a derivative of Carvedilol, a derivative of Carvedilol phosphate, a derivative of Metoprolol Succinate, and a derivative of Nebivolol.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 90.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13817969', '12447558', '14192310', '13140515', '15351465']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8141485377340317
- 35 USC 102 Novelty (BERT): 0.4962628468296762
- Combined Prediction Score: 0.7823599686435961
- Mean Citation Score: 244.78371600000003
- Max Citation Score: 262.2917
- Similarity Product: 208.9849478726685

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test